Related Experiment Video
Updated: Apr 21, 2026
08:38
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
77.5K
An aripiprazole discontinuation syndrome.
Rhode Island Medical Journal (2013)
|June 18, 2014
Summary
Aripiprazole discontinuation syndrome is described, a novel finding in patients with major depressive disorder. This syndrome is relevant for clinicians managing depression treatment.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Major depressive disorder (MDD) is a prevalent and disabling condition.
- Atypical antipsychotics, including aripiprazole, are increasingly used as augmenting agents for MDD.
- Aripiprazole was the first atypical antipsychotic approved for adjunctive treatment of MDD.
Observation:
- This report details the first documented case of an aripiprazole discontinuation syndrome.
- The syndrome emerged following the cessation of aripiprazole treatment in a patient with MDD.
Findings:
- The observed symptoms constitute a distinct clinical syndrome associated with aripiprazole withdrawal.
- This finding highlights potential adverse events not previously characterized.
Implications:
- This case is crucial for psychiatrists and behavioral specialists managing MDD.
- Internists and neurologists should be aware of this syndrome when patients present with relevant symptoms.
- Understanding aripiprazole discontinuation is vital for safe and effective patient care.
More Related Videos
Related Concept Videos
01:20Desensitization and Tachyphylaxis
3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
01:28Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
01:26Psychosis: Goals of Pharmacotherapy
686
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
686
01:21Antipsychotic Drugs: Typical and Atypical Agents
1.3K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.3K
01:20Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
375
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
375